Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
small molecules
Biotech
Merck inks $349M biobucks deal to apply AI to tricky targets
Merck has doubled down on its pact with Variational AI, striking a deal worth up to $349 million to work on small molecules against two targets.
Nick Paul Taylor
Sep 23, 2025 7:00am
Lilly links up with Gate in $856M biobucks deal
Jul 24, 2025 2:32pm
Novo Nordisk inks $812M Deep Apple deal to pursue obesity target
Jun 11, 2025 7:00am
Novo inks $2.2B deal for Septerna's preclinical obesity programs
May 14, 2025 7:00am
Sanofi's oral TNF asset misses mark in phase 2 psoriasis trial
Apr 24, 2025 4:46am
Empress' crown slips as biotech lays off over half of workers
Mar 18, 2025 1:20pm